Free Trial

MaxCyte (MXCT) SEC Filings & 10K Form

MaxCyte logo
$2.02 -0.13 (-6.05%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.04 +0.02 (+0.74%)
As of 07/18/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MaxCyte SEC Filings

DateFilerForm TypeView
06/25/2025
3:40 PM
MaxCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025
3:05 PM
Hemrajani Rekha (Reporting)
MaxCyte (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/23/2025
5:48 PM
Johnston John Joseph (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
5:32 PM
Al-Wakeel Yasir B. (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
5:34 PM
BALTHROP PATRICK J (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
5:37 PM
Brooke William W (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
5:38 PM
Collins Cynthia (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
5:39 PM
DOUGLAS RICHARD (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
5:41 PM
Erck Stanley C (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
5:43 PM
Hemrajani Rekha (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
3:30 PM
MaxCyte (Filer)
Form DEFA14A
05/08/2025
4:04 PM
MaxCyte (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2025
3:58 PM
MaxCyte (Filer)
Form DEF 14A
04/28/2025
4:02 PM
MaxCyte (Filer)
Form ARS
03/20/2025
5:47 PM
MaxCyte (Issuer)
Sandoval David I. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:49 PM
MaxCyte (Issuer)
Soleymannezhad Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:08 PM
MaxCyte (Issuer)
Swirsky Douglas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
7:49 PM
MaxCyte (Issuer)
Sandoval David I. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
7:51 PM
MaxCyte (Issuer)
Soleymannezhad Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
7:31 PM
Masoud Maher (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
7:33 PM
MaxCyte (Issuer)
Swirsky Douglas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:05 PM
MaxCyte (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2025
5:17 PM
CADIAN CAPITAL MANAGEMENT, LP (Filed by)
MaxCyte (Subject)
Form SCHEDULE 13G/A
01/30/2025
6:30 AM
MaxCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
3:13 PM
Johnston John Joseph (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:03 PM
MaxCyte (Issuer)
Sandoval David I. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:30 AM
MaxCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
3:15 PM
Johnston John Joseph (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:30 PM
MaxCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
3:16 PM
Johnston John Joseph (Reporting)
MaxCyte (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:30 PM
Johnston John Joseph (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:01 AM
MaxCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:14 PM
CADIAN CAPITAL MANAGEMENT, LP (Filed by)
MaxCyte (Subject)
Form SC 13G/A
11/08/2024
4:31 PM
BlackRock, Inc. (Filed by)
MaxCyte (Subject)
Form SC 13G/A
11/06/2024
3:22 PM
MaxCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
3:23 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
MaxCyte (Subject)
Form SC 13G/A
10/30/2024
3:15 PM
Johnston John Joseph (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
4:32 PM
Collins Cynthia (Reporting)
MaxCyte (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2024
4:36 PM
Collins Cynthia (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:40 PM
MaxCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
4:03 PM
Erck Stanley C (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Congress Is Talking Crypto. Here’s What It Means for You … (Ad)

Congress is deep into “Crypto Week” — with new bills that could finally bring clarity to digital assets. Crypto analyst Juan Villaverde says Bitcoin will likely keep climbing… but smaller coins could deliver far bigger gains. He’s revealing the altcoins he believes are best positioned for this new regulatory era.

See Juan’s top altcoin picks for the new crypto bull cycle
09/30/2024
3:15 PM
Johnston John Joseph (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2024
3:11 PM
Johnston John Joseph (Reporting)
MaxCyte (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:34 PM
MaxCyte (Issuer)
Soleymannezhad Ali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
4:10 PM
Erck Stanley C (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:36 PM
Erck Stanley C (Reporting)
MaxCyte (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:30 PM
Johnston John Joseph (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:55 PM
MaxCyte (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
3:13 PM
MaxCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
5:57 PM
MaxCyte (Issuer)
Ross Thomas M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
3:39 PM
Johnston John Joseph (Reporting)
MaxCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MXCT) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners